Two doses of thymosin beta-4 during late pregnancy produced longer newborn mice with more advanced development of lungs, heart, kidneys, brain cortex, and notochord compared to untreated controls.
5 organs acceleratedTB4 treatment during pregnancy advanced development of lungs, heart, kidneys, cerebral cortex, and notochord in newborn mice
What the researchers found
Maternal TB4 treatment (6 mg/kg on days E14 and E17) increased newborn cranio-caudal length and accelerated development of lungs, heart, kidneys, cerebral cortex, and notochord compared to control newborns.
Why it matters
Preterm birth is a leading cause of infant mortality, largely because organs haven't finished developing. If TB4 can accelerate organ maturation, it could help premature babies survive with fewer complications.
The numbers in context
6 mice; TB4 6 mg/kg IP on E14 and E17; increased cranio-caudal length; advanced development of lungs, heart, kidney, cerebral cortex, notochord
How the study worked
Animal study. 6 pregnant mice received intraperitoneal TB4 injections (6 mg/kg in PBS) on gestational days E14 and E17. Newborns assessed for body length and organ development by histology.
Who was studied
Pregnant mice and their newborns
What this study cannot tell us
Very small animal study (6 pregnant mice). No functional assessments of organ maturity. Long-term effects on offspring not evaluated. Mouse development may not directly translate to human pregnancy.
How to read the evidence
Low evidence grade: very small animal study (6 mice) with histological endpoints only. No functional assessments or long-term follow-up.
When this study was published
Published in 2021. TB4 research continues primarily in wound healing and regenerative medicine contexts.
The bigger picture
TB4 is already known for wound healing and tissue repair in adults. This study extends its potential to prenatal medicine, suggesting it could promote organ maturation in at-risk pregnancies — a novel application for this well-studied peptide.
Questions still open
- Could TB4 treatment help improve outcomes for premature human infants at risk of underdeveloped organs?
- What is the optimal timing and dosing window for TB4 during pregnancy?
- Does accelerated organ development from TB4 translate to better functional outcomes after birth?
Common questions
What is thymosin beta-4?
Could this help premature babies?
Read the original research
Thymosin beta-4 prenatal administration improves fetal development and halts side effects due to preterm delivery.
European review for medical and pharmacological sciences, 25(1), 431-437
Citation
Faa, G; Piras, M; Mancuso, L; Coni, P; Pichiri, G; Orrù, G; Fanni, D; Gerosa, C; Cao, G; Taibi, R; Pavone, P; Castagnola, M. (2021). Thymosin beta-4 prenatal administration improves fetal development and halts side effects due to preterm delivery.. European review for medical and pharmacological sciences, 25(1), 431-437. https://doi.org/10.26355/eurrev_202101_24411